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Abstract The presenilin-2 (PS2) gene expression pattern in 
AIzheimer's disease (AD) and control brains was examined using 
nonradioactive in situ hybridization. Message for PS2 was 
primarily detectable in neurons, particularly in somal cytoplasm. 
Intense staining signal was most commonly found in large 
pyramidal neurons, whereas moderate or faint staining was 
usually present in smaller neurons. The pattern of PS2 gene 
expression exhibited a laminar distribution proffie in the frontal 
cortex. A small subset of tangle-bearing neurons exhibited PS2 
hybridization signal in AD. PS2 mRNA expression appeared 
correlated to a high degree with lipofuscin autofluorescence in a 
large subset of neurons. 
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1. Introduction 
Alzheimer's disease, the leading cause of dementia in the 
elderly, is characterized by several striking histopathological 
features including abundant senile plaques, neurofibrillary 
tangles, and extensive neuronal death localized primarily to 
vulnerable brain regions, such as the cerebral cortex and hip- 
pocampus, of affected individuals. The etiology of this disease 
is not well understood, however, genetic omponents contrib- 
ute to a significant percentage of cases, particularly in familial 
Alzheimer's disease (FAD). Several genes have been im- 
plicated in the pathogenesis of affected individuals, including 
apolipoprotein E (ApoE) on chromosome 19 [1,2], amyloid 
precursor protein gene (APP) on chromosome 21 [3], preseni- 
lin-1 (PS1/S182) on chromosome 14 [4], and presenilin-2 (PS2/ 
STM-2) on chromosome 1 [5,6]. The allele of ApoE is asso- 
ciated with AD in a major proportion of cases with late onset 
( > 60 years of age [1,2]). The latter three genes (APP, PS1 and 
PS2) are associated with FAD with early onset ( < 60 years of 
age [3-6]). Mutations in APP account for a small portion of 
FAD cases, whereas mutations in PS1 and PS2 genes have 
been found in a majority of FAD cases. Thus far, at least 
22 missense mutations have been identified in the PS1 gene 
[4] and two missense mutations have been described in the 
PS2 gene in early-onset FAD [5,6]. Although the primary 
structure of presenilins uggests that they are integral mem- 
brane proteins, their physiological functions remain presently 
unknown. Presenilins howed a significant homology with C. 
elegans protein Spe 4, which is involved in receptor localiza- 
tion and protein processing [4-6]. Therefore, it has been sug- 
gested that presenilin may participate in APP trafficking or 
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processing and ultimately lead to the abnormal production of 
[3-amyloid, which accumulates in senile plaques and degener- 
ating neurons in AD [4-6]. 
Recently, a partial cDNA ALG-3, which is a mouse homo- 
logue of PS2, has been shown to rescue a T cell hybridoma 
from T receptor- and Fas-induced apoptosis [7]. It is unclear, 
however, whether the full length PS2 cDNA has a similar or 
inverse function, because it is not known whether this partial 
cDNA ALG-3 conferring resistance to cell death is translated 
into a polypeptide. Indeed, neuronal death is a prominent 
feature of AD and several ines of evidence suggest that apop- 
tosis occurs in AD [8-10]. Thus, it is possible that presenilins 
may be associated with neuronal cell death. 
Immunohistochemical evidence has shown that PS-1 pro- 
tein is detectable within neuritic plaques in sporadic AD 
[11], suggesting a role for PS1 protein in the development of 
AD pathology. To date, no data regarding the expression 
pattern of PS2 and its correlation with the pathology of AD 
are available. Therefore, the characterization of expression 
pattern of PS2 in AD brain is prerequisite to understanding 
the role of PS2 in sporadic AD. In the present study, non- 
radioactive in situ hybridization was used in combination with 
immunohistological techniques to examine PS2 mRNA ex- 
pression and correlation with classical pathological lesions in 
sporadic AD and aged control brain. 
2. Materials and methods 
2.1. cDNA cloning and probe preparation 
To obtain a human PS2 cDNA, 1 I.tl of aliquot from the human 
brain cDNA library (Stratagene) was amplified by polymerase chain 
reaction (PCR) with the following primers [6]: forward GCCAA- 
GAATTCGTGGTGCTTCCAGAGGCA (containing the EcoRI re- 
striction site) and reverse GCAGCTCTAGAAAATTCCCTG- 
CAGCTTGCA (containing the Xbal restriction site). PCR was 
performed under the following conditions: 94°C, 1 min; 60°C, 
1 min; and 72°C, 1 min for 30 cycles with the Pwo DNA polymerase 
(Boehringer Mannheim). PCR products were digested by EcoRI and 
XbaI and ligated to a pcDNA3 vector (Invitrogen). The positive insert 
was sequenced on double strands. For in situ hybridization, digoxi- 
genin-labeled antisense and sense riboprobes were prepared using a 
Genius Kit (Boehringer Mannheim). Briefly, EcoRI- or XhaI-linear- 
ized PS2 cDNA in a pcDNA3 vector was transcribed in vitro with 
either SP6 or T7 RNA polymerase to generate antisense and sense 
probes. After transcription, template DNA was digested by RNase- 
free DNase and the digoxigenin-labeled transcripts were precipitated 
using ethanol. 
2.2. Preparation of tissue 
Six cases of clinically and neuropathologically defined AD (average 
age 74 years, average postmortem delay 4.5 h) and four age-matched 
control cases (average age 77 years, average postmortem delay 5 h) 
were used in this study. Frozen brain tissue from frontal cortex was 
fixed in 4% paraformaldehyde in 100 mM Tris buffer (pH 7.4) for 1 2 
h and stored in 20% sucrose in 100 mM Tris buffer overnight until the 
tissue sunk. Fixed tissue was sectioned on a cryostat (30 ktm) and 
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sections were collected in Tris buffer (100 mM, pH 7.4) and digested 
with proteinase K (Boehringer Mannheim) at a final concentration f 
1 lag/ml in 10 mM Tris, pH 8.0 at 37°C for 20 min. This reaction was 
stopped using 100 mM glycine in 100 mM Tris buffer for 30 s, fol- 
lowed by a 4% paraformaldehyde for 10 min. Sections were washed in 
100 mM Tris buffer for subsequent hybridization. 
2.3. In situ hybridization 
The in situ hybridization i free-floating slices was essentially con- 
ducted according to the procedure described previously with slight 
modification [12-14]. Briefly, sections were hybridized overnight 
with the antisense or sense probe at a final concentration f approx- 
imate 100 ng/ml in hybridization solution containing 50% formamide, 
5X SSC, 2 xDenhardt's solution (USB), 10% dextran sulfate, 0.1% 
SDS, 10 mM Tris and 100 ~tg/ml salmon sperm DNA (Sigma) at 
48°C. The sections were then washed in 2x SSC for 5 min and STE 
(500 mM NaCI, 20 mM Tris, pH 7.4, 1 mM EDTA) for 1 min at 
room temperature, followed by treatment with 20 /ag/ml RNase A 
(Boehringer Mannheim) in STE buffer for 30 min at 37°C. Subse- 
quently, sections were washed in 2XSSC and 1 X SSC for 15 min 
each at room temperature and in 0.1 x SSC for 15 rain at 60°C. Sub- 
sequent immunological detection was performed according to the 
manufacturer's instruction (Boehringer Mannheim), sections were 
washed in buffer 1(100 mM Tris, pH 7.5, 150 mM NaCI) for 1 rain 
and incubated in buffer 2 (1% blocking solution) for 20 min, followed 
by the addition of anti-digoxigenin a tibody at a 1:500 dilution with 
buffer 2 and incubated for 1 h at room temperature. The sections were 
washed in buffer 3 (100 mM Tris, 100 mM NaCI, 50 mM MgCI2, pH 
9.5) for 20 min and were incubated with NBT/BCIP (dilution 1:50) in 
buffer 3 overnight in the dark. The color reaction was stopped in the 
water. 
2.4. Immunohistochemistry 
To determine whether PS2 gene expression had any correlation with 
pathological lesions in AD, double-labeling technique for PS2 gene 
expression and immunoreactivity was employed. Briefly, subsequent 
to in situ hybridization by the above methods, ections were subject o 
immunostaining by the following antibodies. Two well-characterized 
monoclonal antibodies, AT8 (Innogenetics, Belgium, 1:5000) and 
PHF-1 (kindly provided by Dr. S. Greenberg; 1:200), were used to 
determine whether PS2 mRNA expression eurons were colocalized 
with neurofibrillary tangles (NFTs). Both antibodies recognize abnor- 
mal phosphorylation f tau protein without showing crossreactivity 
with normal tau (for review see [15]). The AT8 antibody stains intra- 
cellular NFTs as well as pretangle neurons, whereas the PHF-I anti- 
body stains both intracellular NFTs and extracellular NFTs. Addi- 
tionally, a polyclonal antibody (1342) directed against residues 1~12 of 
the 13-amyloid protein (I :200) [16] was used to detect PS2 mRNA 
expression within plaques. After first labeling for PS2 mRNA, the 
sections were then double-labeled with AT8 and PHF-1 or 13A4 anti- 
bodies. Labeling for the second antigen was detected using FITC- 
conjugated IgG (green fluorescence, Sigma). 
3. Results 
3.1. Distribution of PS2 mRNA in AD and control brain 
In situ hybridization using the digoxigenin-labeled probes 
revealed a dense hybridization signal in the sections hybri- 
dized with the antisense probes, whereas no significant hybri- 
dization signal was observed in the sections hybridized with 
sense probes. Figs. 1 and 2 show representative microscopic 
views of sections from the frontal cortex stained with anti- 
sense and sense probes. Robust levels of PS2 gene expression 
were found in the gray matter of AD and control brain. 
Furthermore, various degrees of PS2 hybridization signal 
were expressed maximally in neurons within the frontal cor- 
tex. Very little hybridization signal was detectable in white 
matter. The pattern of PS2 gene expression in sections tained 
with antisense probe exhibited a laminar distribution profile. 
Layer I of frontal cortex appeared almost devoid of significant 
hybridization signal. Layers II, III, and V exhibited intense 
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hybridization signal (Fig. 1). Interestingly, large pyramidal 
neurons and their neurites localized in layer III and V usually 
displayed the most intense hybridization signal compared with 
neighboring cells, which exhibited relatively weak staining 
(Fig. 3). PS2 hybridization signal was typically observed in 
the peripheral region of the soma, suggesting that it was pre- 
dominantly located in neurons based on the morphological 
characteristics of the stained cells (Fig. 3). The expression 
difference of PS2 in AD and control brain was also compared. 
In most cases examined, no significant difference in PS2 gene 
expression was apparent between AD and control brain, but 
PS2 mRNA expression in one control case was lighter than 
that in the AD cases examined, and in one AD case, the 
staining signal was stronger than that in the four control 
cases. This did not appear related to postmortem interval or 
any other obvious features of the tissues. 
3.2. PS2 gene expression in neurons correlates with 
neuropathology 
Sections hybridized with digoxigenin-labeled PS2 probes 
were subsequently subjected to immunostaining with AT8/ 
PHF-I antibodies. Double-labeling for PS2 gene expression 
and AT8/PHF-1 immunoreactivity revealed that a small sub- 
set of neurons expressing PS2 gene colocalized with paired 
helical filament (PHF) formation (Fig. 4a,b). PHF was not 
detected in most PS2 expression eurons. Similarly, double- 
labeling for PS2 gene expression and 13-amyloid protein im- 
munoreactivity demonstrated that no significant changes in 
PS2 expression were found within plaques, although intense 
PS2 hybridization signal was occasionally observed within a 
few plaques (data not shown). Interestingly, a significant sub- 
set of neurons expressing PS2 were associated with lipofuscin- 
related autofluorescence (Fig. 5a,b) and lipofuscin-bearing 
neurons were significantly colocalized with PS2 labeled-neu- 
rons in control and AD brain. This was evident in many if not 
to majority of PS2 labeled neurons. 
4. Discussion 
In situ hybridization with digoxigenin-labeled probes offers 
many advantages over the use of radioactive probes. First, the 
signal obtained with digoxigenin-labeled probes provides high 
cellular and morphological resolution with lower levels of 
background. Second, subsequent o in situ hybridization 
with digoxigenin-labeled probes, sections can be double-la- 
beled for further analysis, quantification, and comparison. 
In the present study, the expression patterns of mRNA for 
human PS2 from frontal cortex of AD and aged control brain 
by in situ hybridization analysis revealed several findings. 
First, message for PS2 showed a laminar distribution in cere- 
bral cortex and was primarily detectable in neurons. This 
result is consistent with previous reports from normal human 
temporal obes for PS2 expression visualized by radioactive 
hybridization [17] and is also comparable with PS1 expression 
pattern in murine brain observed using non-radioactive hybri- 
dization and immunohistochemistry [14,18]. Second, stronger 
hybridization signal was found in large neurons while mild or 
weak signal appeared in small neurons. It is well-established 
that the frontal cerebral cortex, one of the most vulnerable 
regions in AD, exhibited specific patterns of neuropathology 
in specific layers of cortex. NFTs are predominantly present in 
the cell bodies of neurons of layers III and V, although there 
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Fig. 1. In situ hybridization of PS2 to frontal cortex of AD using digoxigenin-labeled antisense riboprobes, the pattern of PS2 gene xpression 
exhibited a laminar distribution profile mostly in neurons (x 100). 
Fig. 2. Digoxigenin-labeled s nse riboprobes for PS2 showed no significant hybridization signal in frontal cortex (x 100). 
Fig. 3. High magnification f PS2 gene xpression i neurons. Large pyramidal neurons and their neurites usually displayed intense hybridiza- 
tion signal (arrows) compared with neighboring cells which exhibited weak staining (arrowheads) (X400). 
Fig. 4. Double-labeling for PS2 gene xpression and AT8/PHF-l in AD, a small subset of PS2-1abeled neurons (black arrow, b) were colocal- 
ized with paired helical filament formation (white arrow, a) (x 400). 
Fig. 5. PS2-expressing eurons (black arrow, b) were associated with lipofuscin-related autofluorescence (white arrow, b) (x 400). 
are striking regional differences in the proportion of NFTs in 
these two layers [19,20] and neuritic plaques predominantly 
affect layers II and III [20]. In addition, large neurons in 
neocortical nd hippocampal reas are particularly vulnerable 
to cell death or NFT formation [21], suggesting that either 
there are factors present in some neurons which protect 
them from neurodegeneration or that susceptible neuronal 
populations have some unique properties that lead to neuro- 
degeneration. Our results showing higher PS2 expression in 
large neurons and within neuronal aminar layers (II, III 
and V) of cerebral cortex suggests that PS2 may participate 
in events that lead to neurodegeneration in AD via presently 
unknown pathways. It was recently reported that a partial 
cDNA ALG-3, which is a mouse homologue of PS2, rescues 
T cell hybridoma from T cell receptor- and Fas-induced apop- 
tosis [7]. Furthermore, programmed cell death occurs during 
neuronal development, aging and in the AD brain [8-10]. Our 
previous immunohistochemical evidence showed that apopto- 
tic changes are present in AD brain and the number of neu- 
ronal nuclei displaying the distinct morphology of apoptosis i
much greater in AD than in aged control brain [8,9]. In the 
present study, no significant difference in PS2 mRNA expres- 
sion in AD and control brain was observed. It seems that PS2 
mRNA levels in AD do not correlate with DNA damage. Our 
explanations for this result are as follows. First, eventual de- 
velopment of sporadic pathology may result from the other 
alterations, such as the generation of specific variant tran- 
scripts and truncated transcripts of PS2 gene or its abnormal 
protein expression, rather than PS2 mRNA level changes. In- 
deed, previous reports have demonstrated that specific splice 
variants and truncates of PS1 transcripts were found in spo- 
radic cases of AD [22]. Second, relative PS2 mRNA level may 
be influenced by postmortem which displays varying degrees 
of RNA degradation. This is unlikely however, since postmor- 
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tem delays are short and matched across groups. Third, other 
AD susceptibility genes may contribute to AD. To define the 
exact correlation between DNA damage and PS2 expression, 
double staining for PS2 and DNA damage is needed. 
Our results suggest hat there is no simple relationship be- 
tween PS2 expression and tangle and plaque formation. Se- 
quence comparison of presenilins and Spe 4 has lead to the 
hypothesis that presenilins may have some role in 13-amyloid 
trafficking or processing. There is some evidence supporting 
this hypothesis. For example, a fibroblast cell line isolated 
from a patient with PS1 defect produced abnormally high 13- 
amyloid [23] and PS1 protein appeared in AD neuritic plaques 
[11]. Indeed 13-amyloid is able to induce apoptosis in primary 
culture neurons [24]. The pathological function(s) of PS2 and 
its relationship with 13-amyloid remains to be determined. PS- 
2 as suggested by homology to ALG-3 may play a role in 
neuronal vulnerability to various stimuli that can initiate neu- 
ronal damage and eventually program cell death. 
Lipofuscin accumulation has been considered to be age-re- 
lated, morphological marker of nervous system aging. Lipo- 
fuscin autofluorescent granules were widely observed in brain 
regions such as cerebral cortex and hippocampus in aging rat 
and human, including AD tissue [25,26]. It has been suggested 
that lipofuscin deposits represent the accumulation of the per- 
oxidative action of free radicals on membranes. A significant 
colocalization of PS2 mRNA expression and lipofuscin-re- 
lated autofluorescence in a large subset of neurons from cere- 
bral cortex of AD and aged control brain suggests that PS2 
may have some relationship with lipofuscin deposits via some 
as yet unknown pathway such as lipid peroxidation of neuro- 
nal membrane. Their precise relationships between PS2 and 
lipofuscin deposits needs to be further investigated. 
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